| Literature DB >> 32456687 |
Maren van Son1, Nina Hårdnes Tremoen2,3, Ann Helen Gaustad4,2, Dag Inge Våge3, Teklu Tewoldebrhan Zeremichael2, Frøydis Deinboll Myromslien2, Eli Grindflek4.
Abstract
BACKGROUND: Sperm hyperactive motility has previously been shown to influence litter size in pigs, but little is known about the underlying biological mechanisms. The aim of this study was to use RNA sequencing to investigate gene expression differences in testis tissue from Landrace and Duroc boars with high and low levels of sperm hyperactive motility. Boars with divergent phenotypes were selected based on their sperm hyperactivity values at the day of ejaculation (day 0) (contrasts (i) and (ii) for Landrace and Duroc, respectively) and on their change in hyperactivity between day 0 and after 96 h liquid storage at 18 °C (contrast (iii)).Entities:
Keywords: Gene expression; Hyperactive motility; Pig; RNA sequencing; Sperm hyperactivity; Testis
Mesh:
Year: 2020 PMID: 32456687 PMCID: PMC7249385 DOI: 10.1186/s12917-020-02373-9
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Sperm hyperactivity measurements for the different boars included in this study
| Group | Boar | n (ejaculates) | mean %hyperactivity | SD %hyperactivity | Read depth |
|---|---|---|---|---|---|
| Landrace low day 0 | L1 | 3 | 1.9 | 0.2 | 77.6 |
| L2 | 4 | 1.2 | 0.7 | 107.7 | |
| L3 | 3 | 1.6 | 0.6 | 119.9 | |
| L4 | 3 | 1.6 | 0.2 | 87.7 | |
| Landrace high day 0 | L5 | 3 | 16.4 | 7.3 | 94.6 |
| L6 | 3 | 13.6 | 3.2 | 113.6 | |
| L7 | 4 | 15.5 | 3.1 | 127.4 | |
| L8 | 4 | 12.6 | 3.1 | 139.7 | |
| Landrace low change 96 h vs. day 0 | L9 | 5 | 3.3 | 2.1 | 80.0 |
| L10 | 3 | 2.1 | 1.4 | 78.9 | |
| L11 | 4 | 2.3 | 0.6 | 107.7 | |
| L12 | 3 | 3.0 | 2.8 | 71.2 | |
| Landrace high change 96 h vs. day 0 | L13 | 3 | 11.7 | 7.0 | 121.4 |
| L14 | 4 | 17.3 | 9.0 | 127.4 | |
| L15 | 3 | 16.2 | 3.7 | 84.6 | |
| Duroc low day 0 | D1 | 3 | 3.7 | 0.7 | 68.5 |
| D2 | 3 | 7.0 | 2.8 | 72.0 | |
| D3 | 4 | 9.8 | 2.4 | 77.8 | |
| D4 | 3 | 4.7 | 1.5 | 86.7 | |
| Duroc high day 0 | D5 | 3 | 23.6 | 7.9 | 65.2 |
| D6 | 4 | 23.8 | 3.9 | 74.6 | |
| D7 | 3 | 27.9 | 4.0 | 76.2 | |
| D8 | 3 | 27.4 | 1.4 | 121.2 | |
| D9 | 3 | 27.9 | 8.7 | 195.7 |
The boars of contrast (i) (L1-L8), (iii) (L9-L15) and (ii) (D1-D9) are presented with the number of ejaculates, mean and standard deviation (SD) for %hyperactivity in the ejaculates. Read depth is number of sequenced reads per sample in million
Fig. 1Multidimensional scaling (MDS) plots and Venn diagram for the gene expression data. a and b are MDS plots of contrasts (i) and (iii) in Landrace, respectively, whereas c is of contrast (ii) in Duroc. d shows the number of differentially expressed genes for contrast (i) and (iii) with their overlap
Fig. 2Heatmap for hierarchical clustering of differential gene expression. Each row of the grid corresponds to a different gene and each column represents a sample. The up-regulated (red) and down-regulated (yellow) genes were distinguished between the high versus low sperm hyperactivity groups in a) contrast (i) high versus low hyperactivity at the day of ejaculation in Landrace and b) contrast (iii) high versus low change in levels hyperactivity between day 0 and 96 h storage in Landrace
Differentially expressed genes in common for contrasts (i) high versus low hyperactivity at day 0 in Landrace and (iii) high versus low change in levels of hyperactivity between day 0 and 96 h storage in Landrace
| Gene ID | Gene symbol | Gene name | FDR (i) | FDR (iii) | Count high (i) | Count low (i) | Count high (iii) | Count low (iii) |
|---|---|---|---|---|---|---|---|---|
| DNL-type zinc finger | 4.5e-08 | 1.3e-03 | 182 (± 22) | 1093 (± 95) | 67 (± 22) | 179 (± 40) | ||
| RAB27B, member RAS oncogene family | 2.1e-02 | 7.7e-03 | 1650 (± 1105) | 710 (± 259) | 1706 (± 801) | 519 (± 226) | ||
| ribosomal protein S4, X-linked | 3.0e-02 | 1.0e-02 | 31,095 (± 13,846) | 18,108 (± 5267) | 34,635 (± 13,478) | 14,745 (± 5991) | ||
| methylsterol monooxygenase 1 | 2.3e-02 | 1.0e-02 | 11,766 (± 7534) | 5367 (± 1735) | 11,744 (± 2348) | 4422 (± 2427) | ||
| galectin like | 2.9e-02 | 1.5e-02 | 3051 (± 1446) | 1646 (± 488) | 3916 (± 1783) | 1433 (± 505) | ||
| arylsulfatase family member | 1.1e-02 | 1.5e-02 | 913 (± 303) | 466 (± 108) | 992 (± 131) | 364 (± 110) | ||
| transmembrane protein 225B | 1.7e-03 | 1.5e-02 | 895 (± 330) | 2094 (± 786) | 933 (± 187) | 1479 (± 577) | ||
| CD164 molecule like 2 | 7.3e-03 | 1.5e-02 | 109 (± 73) | 361 (± 182) | 103 (± 18) | 241 (± 63) | ||
| arrestin domain containing | 1.7e-03 | 2.2e-02 | 3734 (± 1606) | 1730 (± 426) | 4836 (± 2569) | 1659 (± 352) | ||
| RAS like estrogen regulated growth inhibitor | 8.2e-04 | 2.2e-02 | 848 (± 607) | 241 (± 65) | 854 (± 625) | 198 (± 97) | ||
| ADP ribosylation factor GTPase activating protein | 1.2e-05 | 2.3e-02 | 322 (± 96) | 1043 (± 387) | 339 (± 84) | 686 (± 240) | ||
| integrin alpha-V precursor | 4.9e-02 | 2.4e-02 | 7399 (± 3982) | 4034 (± 1544) | 8956 (± 4183) | 3467 (± 1892) | ||
| novel gene | novel gene | 4.3e-05 | 2.4e-02 | 553 (± 68) | 1395 (± 316) | 343 (± 181) | 726 (± 375) | |
| mannosidase alpha class 2B | 5.1e-05 | 2.5e-02 | 161 (± 49) | 489 (± 150) | 166 (± 78) | 304 (± 94) | ||
| carnitine O-acetyltransferase | 2.6e-04 | 2.7e-02 | 3346 (± 1334) | 7076 (± 1745) | 3539 (± 1249) | 4976 (± 849) | ||
| grancalcin | 9.9e-03 | 2.8e-02 | 3324 (± 1663) | 1575 (± 516) | 3584 (± 1860) | 1268 (± 665) | ||
| novel gene | novel gene | 0.0002 | 2.8e-02 | 1785 (± 534) | 3575 (± 743) | 1628 (± 671) | 2559 (± 935) | |
| ubiquitin like 4B | 1.4e-05 | 2.8e-02 | 1450 (± 700) | 4446 (± 1009) | 1469 (± 746) | 2832 (± 1106) | ||
| prominin 2 | 2.0e-02 | 2.8e-02 | 76 (± 54) | 210 (± 77) | 74 (± 21) | 200 (± 82) | ||
| IQ motif containing F5 | 8.1e-03 | 2.9e-02 | 18,391 (± 3501) | 26,423 (± 2197) | 16,727 (± 4257) | 20,458 (± 4997) | ||
| huntingtin interacting protein 1 | 8.7e-04 | 3.7e-02 | 3592 (± 993) | 5921 (± 1011) | 2947 (± 1720) | 4441 (± 1402) | ||
| adenosine deaminase CECR1 precursor | 4.2e-02 | 3.8e-02 | 182 (± 47) | 303 (± 68) | 137 (± 36) | 243 (± 27) | ||
| leucine rich repeat containing G protein-coupled | 3.8e-02 | 4.0e-02 | 3815 (± 1202) | 2412 (± 767) | 5078 (± 2454) | 2098 (± 623) | ||
| glycerol-3-phosphate acyltransferase 4 | 1.5e-04 | 4.0e-02 | 6146 (± 1491) | 10,211 (± 2337) | 5818 (± 2115) | 7630 (± 2240) | ||
| fascin-3 | 5.9e-04 | 4.0e-02 | 7738 (± 2188) | 13,775 (± 2808) | 6367 (± 3262) | 10,079 (± 3560) | ||
| testis expressed 44 | 2.1e-04 | 4.4e-02 | 4149 (± 2414) | 11,049 (± 2567) | 4330 (± 2331) | 7558 (± 3339) | ||
| LIM domain only 4 | 3.3e-02 | 4.8e-02 | 831 (± 261) | 465 (± 121) | 989 (± 385) | 368 (± 156) | ||
| ceramide synthase 6 | 3.6e-02 | 4.8e-02 | 4029 (± 1640) | 2452 (± 690) | 6135 (± 3651) | 2277 (± 572) | ||
| thymosin beta 4, Y-linked | 1.8e-02 | 4.8e-02 | 3676 (± 1035) | 2191 (± 602) | 5172 (± 3085) | 1951 (± 352) | ||
| centrin 1 | 3.1e-04 | 4.8e-02 | 31,883 (± 6281) | 54,982 (± 9504) | 30,604 (± 7660) | 38,067 (± 8989) | ||
| Cell division cycle protein 20 homolog | 6.8e-04 | 4.8e-02 | 3008 (± 1098) | 5940 (± 1740) | 3005 (± 1079) | 4302 (± 1296) | ||
| protamine 1 | 8.2e-03 | 4.8e-02 | 82,199 (± 27,212) | 117,697 (± 11,624) | 67,279 (± 46,538) | 100,121 (± 16,807) | ||
| protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 | 1.5e-02 | 4.8e-02 | 2003 (± 748) | 3583 (± 732) | 1930 (± 356) | 3052 (± 895) | ||
| CMT1A duplicated region transcript 4 | 1.7e-03 | 4.8e-02 | 466 (± 116) | 923 (± 210) | 428 (± 121) | 719 (± 219) | ||
| protamine 3 | 8.9e-05 | 4.8e-02 | 2567 (± 1570) | 6555 (± 1223) | 2693 (± 1803) | 4481 (± 1585) | ||
| Rho guanine nucleotide exchange factor 10 like | 1.1e-03 | 4.8e-02 | 134 (± 53) | 356 (± 180) | 140 (± 58) | 279 (± 91) | ||
| zinc and ring finger 4 | 2.4e-05 | 4.8e-02 | 1019 (± 587) | 3079 (± 966) | 1112 (± 647) | 2049 (± 805) | ||
| nudix hydrolase 12 | 2.6e-02 | 4.9e-02 | 792 (± 307) | 419 (± 131) | 928 (± 418) | 340 (± 136) | ||
| chromosome 16 open reading frame 78 | 1.8e-03 | 4.9e-02 | 3755 (± 1189) | 6066 (± 1030) | 3256 (± 1979) | 4673 (± 1694) | ||
| coiled-coil domain containing 17 | 5.9e-06 | 4.9e-02 | 1719 (± 517) | 3650 (± 792) | 1689 (± 730) | 2647 (± 1024) | ||
| adenosine deaminase | 1.7e-02 | 4.9e-02 | 82 (± 23) | 162 (± 37) | 63 (± 34) | 152 (± 65) |
Genes differentially expressed in contrasts (i) and (iii) are presented with gene Ensembl ID, gene symbol, gene name and significance level (FDR) in Landrace (L) for the two contrasts. Moreover, average read counts for the high and low groups are included along with standard deviations
Fig. 3Boxplot showing the differential expression of DNLZ. The most significant gene in common for the Landrace contrasts (i) high versus low hyperactivity at the day of ejaculation in Landrace and (iii) high versus low change in levels hyperactivity between day 0 and 96 h storage in Landrace was DNLZ. The read counts for the high and low groups of animals in these two contrasts are plotted and box edges represents the upper and lower quartile with the median value shown as a bold line in the middle of the box. Whiskers represent 1.5 times the quartile of the data
Gene ontology (GO) functional enrichment analysis for the differentially expressed genes for hyperactivity at day 0 in Landrace
| Category | Term | Description | DE counts | Total in category | |
|---|---|---|---|---|---|
| CC | GO:0070062 | extracellular exosome | 6.58E-06 | 409 | 1371 |
| CC | GO:0005737 | cytoplasm | 1.67E-05 | 616 | 2157 |
| BP | GO:0001701 | in utero embryonic development | 2.73E-05 | 52 | 123 |
| MF | GO:0045296 | cadherin binding | 3.68E-05 | 68 | 174 |
| MF | GO:0000166 | nucleotide binding | 5.37E-05 | 190 | 591 |
| CC | GO:0005925 | focal adhesion | 6.80E-05 | 79 | 213 |
| CC | GO:0061700 | GATOR2 complex | 1.17E-04 | 8 | 9 |
| MF | GO:0005524 | ATP binding | 2.68E-04 | 242 | 792 |
| BP | GO:0060048 | cardiac muscle contraction | 2.89E-04 | 11 | 16 |
| CC | GO:0005634 | nucleus | 2.98E-04 | 715 | 2589 |
| CC | GO:0005813 | centrosome | 7.63E-04 | 103 | 310 |
| BP | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 9.37E-04 | 5 | 5 |
Gene ontology results are presented with category (CC cellular component, BP biological process, MF molecular function), term, description, significant level (p-value), gene count in differentially expressed genes (DE) and total number of genes in category
Gene ontology (GO) functional enrichment analysis for the differentially expressed genes for change in hyperactivity between day 0 and 96 h storage in Landrace
| Category | Term | Description | DE counts | Total in category | |
|---|---|---|---|---|---|
| CC | GO:0005615 | extracellular space | 2.37E-05 | 12 | 360 |
| CC | GO:0005576 | extracellular region | 2.17E-04 | 9 | 247 |
| BP | GO:0006154 | adenosine catabolic process | 2.31E-04 | 2 | 3 |
| CC | GO:0009897 | external side of plasma membrane | 4.33E-04 | 5 | 88 |
| MF | GO:0005125 | cytokine activity | 4.60E-04 | 3 | 21 |
| BP | GO:0071985 | multivesicular body sorting pathway | 7.27E-04 | 2 | 6 |
| CC | GO:0032585 | multivesicular body membrane | 9.55E-04 | 2 | 6 |
Gene ontology results are presented with category (CC cellular component, BP biological process, MF molecular function), term, description, significant level (p-value), gene count in differentially expressed genes (DE) and total number of genes in category
Effects of putative SNPs
| SNP effect | All dataset | Joined with (i) | Joined with (iii) | Common (i) and (iii) |
|---|---|---|---|---|
| 3’UTR | 16,507 | 1665 | 72 | 4 |
| 5’UTR | 2741 | 382 | 16 | 8 |
| Frameshift | 20 | 2 | 0 | 0 |
| Missense | 3452 | 477 | 27 | 7 |
| Start lost | 8 | 0 | 0 | 0 |
| Stop lost | 8 | 2 | 0 | 0 |
| Stop gained | 19 | 1 | 0 | 0 |
| Splice region variant | 722 | 90 | 3 | 1 |
| Splice acceptor | 19 | 5 | 0 | 0 |
| Splice donor | 30 | 6 | 0 | 0 |
| Coding sequence variant | 4 | 0 | 0 | 0 |
| Inframe deletion | 47 | 1 | 0 | 0 |
| Inframe insertion | 20 | 3 | 0 | 0 |
| Protein altering variant | 1 | 0 | 0 | 0 |
| Synonymous | 77,186 | 704 | 29 | 8 |
| High | 104 | 16 | 0 | 0 |
| Moderate | 3518 | 481 | 27 | 7 |
| Low | 8343 | 761 | 32 | 9 |
| Modifier | 243,587 | 22,707 | 723 | 323 |
SNP effect according to Ensembl VEP for putative variants detected using the animals of contrasts (i) and (iii). The results are shown for all filtered variants in the Landrace dataset and variants in differentially expressed genes. Some variants have more than one predicted effect